✨ Medicines Notices




NEW ZEALAND GAZETTE, No. 109 β€” 1 OCTOBER 2015

New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Winglore
Ipilimumab 50mg/10mL
Concentrate for injection
Bristol-Myers Squibb (NZ) Limited
Baxter Pharmaceutical Solutions LLC, Indiana, United States of America

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Winglore
Ipilimumab 200mg/40mL
Concentrate for injection
Bristol-Myers Squibb (NZ) Limited
Baxter Pharmaceutical Solutions LLC, Indiana, United States of America

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Yervoy
Ipilimumab 50mg/10mL
Concentrate for injection
Bristol-Myers Squibb (NZ) Limited
Baxter Pharmaceutical Solutions LLC, Indiana, United States of America

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Yervoy
Ipilimumab 200mg/40mL
Concentrate for injection
Bristol-Myers Squibb (NZ) Limited
Baxter Pharmaceutical Solutions LLC, Indiana, United States of America

Dated this 25th day of September 2015.

CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

2015-go5799

Revocation of Consent to the Distribution of Medicines

Pursuant to section 35(1)(c) of the Medicines Act 1981, the Minister of Health hereby revokes consent to the distribution in New Zealand of the following medicines:

Schedule

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Ropaccord
Ropinirole hydrochloride 0.285mg equivalent to Ropinirole 0.25mg
Film coated tablet
Accord Healthcare NZ Limited
Intas Pharmaceuticals Limited, Gujarat, India

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Ropaccord
Ropinirole hydrochloride 0.57mg equivalent to Ropinirole 0.5mg
Film coated tablet
Accord Healthcare NZ Limited
Intas Pharmaceuticals Limited, Gujarat, India

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Ropaccord
Ropinirole hydrochloride 1.14mg equivalent to Ropinirole 1mg
Film coated tablet
Accord Healthcare NZ Limited
Intas Pharmaceuticals Limited, Gujarat, India

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Ropaccord
Ropinirole hydrochloride 2.28mg equivalent to Ropinirole 2mg
Film coated tablet
Accord Healthcare NZ Limited
Intas Pharmaceuticals Limited, Gujarat, India

56



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2015, No 109





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of New Medicines (continued from previous page)

πŸ₯ Health & Social Welfare
25 September 2015
Medicines, Distribution, Winglore, Yervoy, Ipilimumab, Bristol-Myers Squibb, Baxter Pharmaceutical Solutions
  • CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health

πŸ₯ Revocation of Consent to the Distribution of Medicines

πŸ₯ Health & Social Welfare
Medicines, Revocation, Ropaccord, Ropinirole, Accord Healthcare, Intas Pharmaceuticals